Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Bullboard Posts
Comment by flad101on Apr 16, 2020 3:35pm
97 Views
Post# 30918321

RE:RE:RE:RE:RE:Ontario online pot purchases jump 600% amid COVID-19 pandemi

RE:RE:RE:RE:RE:Ontario online pot purchases jump 600% amid COVID-19 pandemiI disagree with you.  150% is unreasonable.  Why do you think there is no volume.  Nobody is buying because it's overpriced.   Looks at Valens yesterday.  EPS expected was .06.  Actual was .02.  Price goes down.   All of your other evaluations are useless.  Adjusted this and adjusted that.  There is one thing in investing.  That's the bottom line.   Net eps. I read this boards and think why people are so misguided.  People go ahead and buy if this is what you think.   But look at the history out here.  More quotes about this is a great company and great future keep buying and we will prosper, yet the trend has been negative and no signs of slowing down. If you want to look at other methods look at price to book type evaluations.   This company may make a comeback at some point and time. But not when it's making .01 per share.  
Bullboard Posts